SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-039407
Filing Date
2020-06-30
Accepted
2020-06-30 13:13:42
Documents
1
Period of Report
2020-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5779
  Complete submission text file 0001209191-20-039407.txt   7133
Mailing Address C/O OREXIGEN THERAPEUTICS, INC. 3344 N TORREY PINES CT, #200 LA JOLLA CA 92037
Business Address
NARACHI MICHAEL (Reporting) CIK: 0001380022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 201001666

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences